First persons receive injections of "made-in-Vietnam" COVID-19 vaccine
The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers, one man and two women aged 20-25, receiving injections at the Military Medical Academy.
The first person is vaccinated with Nanocovax, a made-in-Vietnam vaccine, at the Military Medical Academy on December 17. (Photo: VNA)
Hanoi (VNA) – The first human trial ofCOVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first threevolunteers, one man and two women aged 20-25, receiving injections at theMilitary Medical Academy.
Nanocovax, developed by the Nanogen PharmaceuticalBiotechnology JSC, is the first Vietnam-made COVID-19 vaccine to enter humantrials, with another two from other manufacturers to follow in February andMarch 2021.
The first candidates are among 60 volunteers, aged 18-50,selected for the first phase of the vaccine trials. They are divided into threegroups for receiving three doses of 25 mcg, 50 mcg and 75 mcg.
With safety staying first in vaccine clinical trials, thefirst volunteers received the minimum dose of 25 mcg. They will stay at separaterooms at the Military Medical Academy for the first 72 hours for medicalassessment. They will continue to be closely monitored at their residences forthe next 56 days.
A team of more than 40 medical experts has been set up todeal with unwanted side effects after the vaccination.
Prof. Dr. Do Quyet, Director of the Military Medical Academy, speaks to the press following the trial vaccination. (Photo: VNA)
“In the world, there have been very few vaccine trialswith unexpected reactions, and we hope Nanocovax vaccine is no exception,” saidProf. Dr. Do Quyet, Director of the Military Medical Academy.
“To ensure the highest safety for the volunteers, we hadto best prepare, even for the life-threatening circumstances,” he said.
“We pledge to assess [the vaccine] objectively, honestly,and transparently, and submit the proposals to the health ministry forlater-stage trials,” he continued./.
Cambodian Prime Minister Hun Sen said that the Ministers of Health and Finance have already signed a deal to obtain 20 percent of a vaccine through COVAX.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
The first person is vaccinated with Nanocovax, a made-in-Vietnam vaccine, at the Military Medical Academy on December 17. (Photo: VNA) 
Prof. Dr. Do Quyet, Director of the Military Medical Academy, speaks to the press following the trial vaccination. (Photo: VNA)
